Abstract
In the last 20 years specific methods of dialysis, different from those usually provided in chronic uremic patients has been developed for CRRT in ICUs patients. In the last 20 years, clinical experiences have demonstrated that continuous and intermittent techniques (prolonged intermittent renal replacement therapy, PIRRT) are overlapping for efficacy and patients survival. In addition, in this brief review we focus on recent data shedding light on two crucial points of high clinical impact on CRRT practice, such as dose of dialysis and anticoagulation of extracorporeal circuit.
Keywords
- Continuous Renal Replacement Therapy
- Extracorporeal Circuit
- Regional Citrate Anticoagulation
- Dialysis Dose
- Blood Circuit
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F (1977) Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55:1121–1122
Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346:305–310
Vinsonneau C, Camus C, Combes A et al (2006) Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368:379–385
Vesconi S, Cruz DN, Fumagalli R et al (2009) Dose Response Multicentre International collaborative Initiative (DO-RE-MI Study Group). Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13(2):R57
Kellum JA, Ronco C (2010) Dialysis: results of renal: what is the optimal CRRT target dose? Nat Rev Nephrol 6:191–192
Granado RC, Macedo E, Chertow GM et al (2011) Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clin J Am Soc Nephrol 6:467–475
Paganini EP, Tapolyai M, Goormastic M (1996) Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 28(3):S81–S89
Ronco C, Bellomo R, Homel P et al (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26–30
VA/NIH Acute Renal Failure Trial Network (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20
RENAL Replacement Therapy Study Investigators (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638
Metnitz PG, Krenn CG, Steltzer H et al (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30:2051–2058
Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G (2010) Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 36:1735–1743
van de Wetering J, Westendorp RG, van der Hoeven JG et al (1996) Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 7:145–150
Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:179–184
Davenport A (2009) Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology 14:455–461
Reeves JH, Cumming AR, Gallagher L, O’Brien JL, Santamaria JD (1999) A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 27:2224–2228
Jeffrey RF, Khan AA, Douglas JT, Will EJ, Davison AM (1993) Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit. Artif Organs 17:717–720
de Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF (2000). Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study. Crit Care Med 28:421–425
Mariano F (2012) Il citrato: un diverso approccio mentale all’anticoagulazione del circuito extracorporeo. G Ital Nefrol 19:27–32
Morita Y, Johnson RW, Dorn RE, Hall DS (1961) Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 242:32–43
Mehta RL, McDonald BR, Aguilar MM, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976–981
Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T (2005) Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 20:155–161
Symons JM, Chua AN, Somers MJ et al (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the Prospective Pediatric Continuous Renal Replacement Therapy Registry. Clin J Am Soc Nephrol 2:732–738
Mariano F, Pozzato M, Canepari G et al (2011) Renal replacement therapy in intensive care units: a survey of nephrological practice in northwest Italy. J Nephrol 24:165–176
Mariano F, Morselli M, Bergamo D et al (2011) Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant 26:3882–3888
Morgera S, Schneider M, Slowinski T et al (2009) A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 37:2018–2024
Oudemans-van Straaten HM, Bosman RJ, Koopmans M et al (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37:545–552
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Mariano, F. (2014). Continuous Renal Replacement Therapy (CRRT) in Intensive Care. In: Allaria, B. (eds) Practical Issues in Anesthesia and Intensive Care 2013. Springer, Milano. https://doi.org/10.1007/978-88-470-5529-2_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-5529-2_8
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5528-5
Online ISBN: 978-88-470-5529-2
eBook Packages: MedicineMedicine (R0)